Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Eficacia del benralizumab en la granulomatosis eosinofílica con poliangitis con miositis y miocardiopatía. Estudio de dos casos. Local targets link to admitted publications; unresolved targets remain external evidence.
The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)
10.1002/art.1780330806 · 1990 · External reference
Benralizumab versus mepolizumab for eosinophilic granulomatosis with polyangiitis
10.1056/nejmoa2311155 · 2024 · External reference
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): a European real-life retrospective comparative study
10.1016/j.jaut.2025.103398 · 2025 · External reference
Cardiac involvement in eosinophilic granulomatosis with polyangiitis: acute eosinophilic myocarditis and chronic inflammatory cardiomyopathy
10.1093/rheumatology/keae085 · 2025 · External reference
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) presenting as diffuse myositis
10.1186/1471-2474-15-388 · 2014 · External reference
